Integra LifeSciences Holdings Corp (IART) stock
IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/308% below fair value
$13.55−0.43 (-3.08%)
Close on Nov 17, 2026Market cap $1.05BP/E 79.7Yield –
Integra LifeSciences ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Integra LifeSciences's ebitda for the twelve months ending Jun 30, 2020 was $170.98M, down 30.7% year over year. For fiscal 2019 it was $203.22M, down 8.3% from the year before. Over ten years it grew 4.0% a year on average. The highest annual figure on record is $221.73M in fiscal 2018.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $203.22M | -8.3% |
| FY2018 | Dec 31, 2018 | $221.73M | +65.8% |
| FY2017 | Dec 31, 2017 | $133.75M | -28.9% |
| FY2016 | Dec 31, 2016 | $188.01M | +35.8% |
| FY2015 | Dec 31, 2015 | $138.45M | +21.1% |
| FY2014 | Dec 31, 2014 | $114.29M | +72.2% |
| FY2013 | Dec 31, 2013 | $66.39M | -47.5% |
| FY2012 | Dec 31, 2012 | $126.39M | +20.3% |
| FY2011 | Dec 31, 2011 | $105.08M | -23.8% |
| FY2010 | Dec 31, 2010 | $137.87M | +0.3% |
| FY2009 | Dec 31, 2009 | $137.51M | +76.0% |
| FY2008 | Dec 31, 2008 | $78.13M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2020 | Jun 30, 2020 | $43.76M | -39.9% |
| Q1 FY2020 | Mar 31, 2020 | $56.25M | -5.3% |
| Q4 FY2019 | Dec 31, 2019 | $63.96M | +3.5% |
| Q3 FY2019 | Sep 30, 2019 | $7.01M | -86.7% |
| Q2 FY2019 | Jun 30, 2019 | $72.85M | +33.6% |
| Q1 FY2019 | Mar 31, 2019 | $59.40M | +12.8% |
| Q4 FY2018 | Dec 31, 2018 | $61.79M | +82.4% |
| Q3 FY2018 | Sep 30, 2018 | $52.73M | +66.8% |
| Q2 FY2018 | Jun 30, 2018 | $54.54M | +41.4% |
| Q1 FY2018 | Mar 31, 2018 | $52.68M | +77.5% |
| Q4 FY2017 | Dec 31, 2017 | $33.88M | -42.7% |
| Q3 FY2017 | Sep 30, 2017 | $31.61M | – |
| Q2 FY2017 | Jun 30, 2017 | $38.58M | – |
| Q1 FY2017 | Mar 31, 2017 | $29.68M | – |
| Q4 FY2016 | Dec 31, 2016 | $59.08M | – |
See a number that looks wrong?